Thus, our data classified that si-circUBE2K-related BC cell inhibitory could be reversed via silencing miR-516b-5p or over-expressing of ARHGAP5 through a RhoA dependent mechanism. This evidence concerns the gene ARHGAP5 and breast cancer.